Premium
Long‐term outcomes after treatment of bare‐metal stent restenosis with paclitaxel‐coated balloon catheters or everolimus‐eluting stents: 3‐year follow‐up of the TIS clinical study
Author(s) -
Pleva Leos,
Kukla Pavel,
Zapletalova Jana,
Hlinomaz Ota
Publication year - 2018
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.27688
Subject(s) - medicine , paclitaxel , restenosis , balloon , bare metal , everolimus , stent , bare metal stent , term (time) , angioplasty , surgery , drug eluting stent , chemotherapy , physics , quantum mechanics
The efficacy of paclitaxel-eluting balloon catheters (PEB) and drug-eluting stents for treatment of bare-metal stent restenosis (BMS-ISR) have been demonstrated in several studies with follow-up times of 9 to 12 months; however, the long-term outcomes of ISR treatment are less defined.